| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698042 | Clinical Oncology | 2017 | 8 Pages |
Abstract
Radiotherapy may effectively extend EGFR TKI therapy for patients with oligoprogression on TKI. Improved PFS and overall survival were observed, although potential biases should not be overlooked. Further randomised studies are warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
O.S.H. Chan, V.H.F. Lee, T.S.K. Mok, F. Mo, A.T.Y. Chang, R.M.W. Yeung,